Skip to main content

Decoding the Data: Understanding the Impact of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds

This session will assess the differences in the quality of clinical trials on the use of skin substitutes in chronic wounds, specifically focusing on the importance of identifying inherent bias in clinical study design in the age of evidence-based medicine. This symposium will also include an overview of the recent Agency for Healthcare Research & Quality (AHRQ) 2020 Technical Assessment on Skin Substitutes document and include a brief review of the MiMedx clinical studies that were evaluated in the ARHQ document.

Register Now
Care Setting

Log In

If you are already registered, look up the email address you used to register to log in below.


  • Frances L. Game BSc(Hons), MBBCh(Hons), FRCP
    Consultant Diabetologist and Director of R&D
    Derbyshire, England, UK
  • William H. Tettelbach, MD, FACP, FIDSA, FUHM, CWS
    Associate Chief Medical Officer